Teladoc Health (NYSE:TDOC) Trading 9.4% Higher – Still a Buy?

Shares of Teladoc Health, Inc. (NYSE:TDOC) traded up 9.4% during mid-day trading on Tuesday . The stock traded as high as $7.92 and last traded at $7.9650. 5,488,002 shares traded hands during trading, an increase of 21% from the average session volume of 4,523,786 shares. The stock had previously closed at $7.28.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Evercore ISI dropped their price target on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a research report on Thursday, October 30th. Citigroup increased their price objective on shares of Teladoc Health from $9.50 to $10.50 and gave the company a “neutral” rating in a research note on Tuesday, October 21st. Zacks Research downgraded shares of Teladoc Health from a “strong-buy” rating to a “hold” rating in a report on Monday, November 10th. BMO Capital Markets started coverage on shares of Teladoc Health in a report on Thursday, November 13th. They issued a “market perform” rating and a $8.00 price target on the stock. Finally, Bank of America dropped their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “neutral” rating for the company in a research note on Tuesday, November 25th. Five analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $9.60.

Teladoc Health Stock Performance

The company has a market capitalization of $1.41 billion, a PE ratio of -6.22 and a beta of 2.04. The stock’s fifty day simple moving average is $7.44 and its 200-day simple moving average is $7.80. The company has a debt-to-equity ratio of 0.71, a quick ratio of 2.60 and a current ratio of 2.70.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.05. The business had revenue of $626.44 million during the quarter, compared to analyst estimates of $625.66 million. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.59%. The company’s revenue was down 2.2% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.19) earnings per share. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. As a group, equities analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Charles Divita III sold 17,138 shares of the firm’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $7.63, for a total transaction of $130,762.94. Following the sale, the chief executive officer owned 201,036 shares in the company, valued at $1,533,904.68. This trade represents a 7.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Fernando M. Rodrigues sold 4,209 shares of Teladoc Health stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $7.48, for a total value of $31,483.32. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 33,288 shares of company stock worth $251,684. 0.58% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Y Intercept Hong Kong Ltd purchased a new position in shares of Teladoc Health in the 2nd quarter valued at $2,722,000. Farther Finance Advisors LLC boosted its position in Teladoc Health by 424.5% during the 2nd quarter. Farther Finance Advisors LLC now owns 9,960 shares of the health services provider’s stock worth $87,000 after purchasing an additional 8,061 shares during the period. Ameritas Advisory Services LLC acquired a new stake in Teladoc Health in the 2nd quarter valued at $78,000. Wealth Management Associates Inc. purchased a new position in Teladoc Health in the second quarter valued at about $509,000. Finally, Strs Ohio acquired a new position in shares of Teladoc Health during the first quarter worth about $349,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.